Lithium in patients with amyotrophic lateral sclerosis (LiCALS) : a phase 3 multicentre, randomised, double-blind, placebo-controlled trial

Al-Chalabi, A, Allen, C M, Counsell, C E, Farrin, A, Dickie, B G, Kelly, J B, Leigh, P N, Murphy, C L, Payan, C A M, Reynolds, G, Shaw, P J, Steen, I N, Thornhill, M, Waters, J, Zajicek, J, Young, C A, Morrison, K E, Dhariwal, S, Hornabrook, R, Savage, L, Burn, D J, Khoo, T K, Kelly, J, Dougherty, A, Wijesekera, L, Thornhill, M, Ellis, C M, O'Hanlon, K, Panicker, J, Pate, L, Ray, P, Wyatt, L, Copeland, L, Ealing, J, Hamdalla, H, Leroi, I, Murphy, C, O'Keeffe, F, Oughton, E, Partington, L, Paterson, P, Rog, D, Sathish, A, Sexton, D, Smith, J, Vanek, H, Dodds, S, Williams, T L, Clarke, J, Eziefula, C, Howard, R, Orrell, R, Sidle, K, Sylvester, R, Barrett, W, Merritt, C, Talbot, K, Turner, M R, Whatley, C, Williams, C, Williams, J, Cosby, C, Hanemann, C O, Imam, I, Phillips, C, Timings, L, Crawford, S E, Hewamadduma, C, Hibberd, R, Hollinger, H, McDermott, C, Mills, G, Rafiq, M, Taylor, A, Waines, E, Walsh, T, Addison-Jones, R, Birt, J, Hare, M & Majid, T 2013, 'Lithium in patients with amyotrophic lateral sclerosis (LiCALS) : a phase 3 multicentre, randomised, double-blind, placebo-controlled trial', The Lancet neurology, vol. 12, no. 4, pp. 339-345. https://doi.org/10.1016/S1474-4422(13)70037-1